He can read your emails all day, Merck will say whether they want to make that deal or not. If PSA data is what they're waiting for before they pick up our P3, than you got me. Axal has been our lead product for years with no success in partnering.
My biggest concern is over NEO costs and whether we continue to fund it. They've blown through countless sums of cash and acted for years like they would have cash coming in. NEVER HAPPEND. We're BROKE.
News 
Market Data 
Discover 
AI
